Researchers are looking into several drugs that can potentially treat graft-versus-host disease, a side effect of bone marrow transplant in which the transplanted cells attack the patient's skin and organs. Dor BioPharma is currently gathering additional evidence on the efficacy of its steroid orBec to treat the side effect, while other scientists are testing the experimental drug Prochymal and the cancer drug cyclophosphamide.

Related Summaries